Research Centre for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
University College London Medical School (UCL), London, UK; 4Watford General Hospital, Watford, United Kingdom.
Curr Stem Cell Res Ther. 2021;16(6):730-744. doi: 10.2174/1574888X16666210120101600.
The potential use of growth factors in stem cell-based therapies for the repair and regeneration of tissues and organs offers a paradigm shift in regenerative medicine. Growth factors are critical signalling molecules that play an important role in tissue development and remodelling. Plasma rich in growth factor (PRGF) is a biotechnological strategy for the harvesting of the active substances of platelets, including growth factors, from the patient's blood. Because of their tremendous essential growth factor and bioactive agents, as well as their paracrine mechanisms, PRGF has been used as an efficacious option and adjuvant biological therapy in the repair and replacement of damaged organs. This article provides an overview of PRGF extraction and its properties and critically reviewed its clinical benefit and clinical trials in the treatment and regeneration of human organs. Regenerative medicine is a multi-billion-dollar industry with huge interest to clinicians, academics and industries, being considered as an emerging technology.
生长因子在基于干细胞的组织和器官修复和再生疗法中的潜在应用为再生医学带来了范式转变。生长因子是关键的信号分子,在组织发育和重塑中发挥着重要作用。富含生长因子的血浆(PRGF)是一种从患者血液中提取血小板的活性物质(包括生长因子)的生物技术策略。由于其具有巨大的必需生长因子和生物活性物质,以及旁分泌机制,PRGF 已被用作受损器官修复和替代的有效选择和辅助生物治疗。本文概述了 PRGF 的提取及其特性,并对其在治疗和再生人体器官中的临床益处和临床试验进行了批判性回顾。再生医学是一个价值数十亿美元的产业,引起了临床医生、学者和行业的极大兴趣,被认为是一种新兴技术。